Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
$0.22
$0.22
$0.17
$0.40
$6.47M0.521,730 shsN/A
Melinta Therapeutics Inc stock logo
MLNT
Melinta Therapeutics
$0.48
$0.31
$10.10
$6.88M4.16713,628 shsN/A
Reliv' International, Inc. stock logo
RELV
Reliv' International
$3.85
$3.51
$2.50
$4.42
$6.72M-0.123,200 shs125 shs
XTLB
XTL Biopharmaceuticals
$2.40
-6.3%
$3.99
$1.73
$6.69
$13.08M1.21136,363 shs6,181 shs
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
0.00%0.00%-6.36%-12.96%-40.61%
Melinta Therapeutics Inc stock logo
MLNT
Melinta Therapeutics
0.00%0.00%0.00%0.00%0.00%
Reliv' International, Inc. stock logo
RELV
Reliv' International
0.00%+1.32%-3.75%-2.04%+5.48%
XTLB
XTL Biopharmaceuticals
-1.16%+3.64%-8.90%+212.20%+109.82%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
N/AN/AN/AN/AN/AN/AN/AN/A
Melinta Therapeutics Inc stock logo
MLNT
Melinta Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Reliv' International, Inc. stock logo
RELV
Reliv' International
N/AN/AN/AN/AN/AN/AN/AN/A
XTLB
XTL Biopharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
N/AN/AN/AN/A
Melinta Therapeutics Inc stock logo
MLNT
Melinta Therapeutics
N/AN/AN/AN/A
Reliv' International, Inc. stock logo
RELV
Reliv' International
N/AN/AN/AN/A
XTLB
XTL Biopharmaceuticals
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
$50.67M0.13$0.04 per share5.75$0.63 per share0.34
Melinta Therapeutics Inc stock logo
MLNT
Melinta Therapeutics
$96.43M0.00N/AN/A$16.96 per share0.00
Reliv' International, Inc. stock logo
RELV
Reliv' International
$35.06M0.19$0.09 per share44.53$6.36 per share0.61
XTLB
XTL Biopharmaceuticals
N/AN/AN/AN/A$0.73 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
-$30K-$0.01N/AN/A-0.76%-2.05%-1.47%5/6/2024 (Estimated)
Melinta Therapeutics Inc stock logo
MLNT
Melinta Therapeutics
-$157.19M-$17.72N/AN/AN/A-393.39%-101.29%-28.68%N/A
Reliv' International, Inc. stock logo
RELV
Reliv' International
-$440KN/AN/AN/A-0.61%-1.89%-1.31%N/A
XTLB
XTL Biopharmaceuticals
-$1.35M-$0.42N/AN/AN/A-73.05%-68.83%5/21/2024 (Estimated)

Latest MLNT, INBP, RELV, and XTLB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/12/2024Q2 2024
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
N/A-$0.01-$0.01-$0.01N/A$11.51 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
N/AN/AN/AN/AN/A
Melinta Therapeutics Inc stock logo
MLNT
Melinta Therapeutics
N/AN/AN/AN/AN/A
Reliv' International, Inc. stock logo
RELV
Reliv' International
N/AN/AN/AN/AN/A
XTLB
XTL Biopharmaceuticals
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
N/A
2.93
0.84
Melinta Therapeutics Inc stock logo
MLNT
Melinta Therapeutics
1.11
1.03
0.72
Reliv' International, Inc. stock logo
RELV
Reliv' International
0.05
1.70
1.04
XTLB
XTL Biopharmaceuticals
N/A
14.09
N/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
25.25%
Melinta Therapeutics Inc stock logo
MLNT
Melinta Therapeutics
18.02%
Reliv' International, Inc. stock logo
RELV
Reliv' International
7.95%
XTLB
XTL Biopharmaceuticals
4.40%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Integrated BioPharma, Inc. stock logo
INBP
Integrated BioPharma
14130.10 million16.37 millionNot Optionable
Melinta Therapeutics Inc stock logo
MLNT
Melinta Therapeutics
29013.75 millionN/AOptionable
Reliv' International, Inc. stock logo
RELV
Reliv' International
911.75 millionN/ANot Optionable
XTLB
XTL Biopharmaceuticals
N/A5.45 million3.87 millionNot Optionable

MLNT, INBP, RELV, and XTLB Headlines

SourceHeadline
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.03%U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.03%
msn.com - March 20 at 8:50 PM
US Stocks Edge Lower Ahead Of Feds Decision; General Mills Earnings Top ViewsUS Stocks Edge Lower Ahead Of Fed's Decision; General Mills Earnings Top Views
msn.com - March 20 at 3:48 PM
Dow Surges 350 Points; Fed Holds Rates SteadyDow Surges 350 Points; Fed Holds Rates Steady
markets.businessinsider.com - March 20 at 3:48 PM
Crude Oil Surges 2%; Signet Jewelers Shares Spike HigherCrude Oil Surges 2%; Signet Jewelers Shares Spike Higher
markets.businessinsider.com - March 20 at 3:48 PM
XTL To Aquire The Social ProxyXTL To Aquire The Social Proxy
globenewswire.com - March 20 at 10:15 AM
XTL Biopharmaceuticals Ltd ADR (XTLB)XTL Biopharmaceuticals Ltd ADR (XTLB)
investing.com - February 17 at 10:28 AM
Call for ProposalsCall for Proposals
raps.org - February 11 at 2:00 PM
XTL Biopharmaceuticals Ltd (H2K2.MU)XTL Biopharmaceuticals Ltd (H2K2.MU)
finance.yahoo.com - October 23 at 11:13 PM
XTL Biopharmaceuticals Ltd.: XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyXTL Biopharmaceuticals Ltd.: XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
finanznachrichten.de - October 23 at 12:16 AM
XTL Biopharmaceuticals Ltd.: XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in IsraelXTL Biopharmaceuticals Ltd.: XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel
finanznachrichten.de - October 21 at 8:22 AM
XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in IsraelXTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel
finance.yahoo.com - October 20 at 7:35 PM
XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyXTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
finance.yahoo.com - October 20 at 7:35 PM
Is X T L Biopharmaceuticals Ltd (ADR) (XTLB) Stock a Good Investment?Is X T L Biopharmaceuticals Ltd (ADR) (XTLB) Stock a Good Investment?
aaii.com - March 30 at 3:19 PM
XTLB XTL Biopharmaceuticals Ltd.XTLB XTL Biopharmaceuticals Ltd.
seekingalpha.com - October 1 at 8:47 PM
X T L Biopharmaceuticals LtdX T L Biopharmaceuticals Ltd
reuters.com - August 8 at 10:32 PM
LIFE, TBLT and XTLB among pre market gainersLIFE, TBLT and XTLB among pre market gainers
seekingalpha.com - July 23 at 7:53 AM
XTL Biopharmaceuticals Year to Date Total Returns (Daily)XTL Biopharmaceuticals Year to Date Total Returns (Daily)
ycharts.com - December 18 at 11:24 PM
XTL Biopharmaceuticals Dividend Per Share (TTM)XTL Biopharmaceuticals Dividend Per Share (TTM)
ycharts.com - December 18 at 1:03 AM
XTL Biopharmaceuticals Ltd. (XTLB)XTL Biopharmaceuticals Ltd. (XTLB)
uk.finance.yahoo.com - December 15 at 10:18 AM
X.T.L. Biopharmaceuticals Ltd. - ADRX.T.L. Biopharmaceuticals Ltd. - ADR
money.usnews.com - September 26 at 12:03 AM
XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) Up 1.8% This Year: What Should You Expect Next?XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) Up 1.8% This Year: What Should You Expect Next?
stocksregister.com - August 23 at 4:44 PM
Is XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) Expensive At $4.67? Here’s How To Know.Is XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) Expensive At $4.67? Here’s How To Know.
marketingsentinel.com - August 20 at 5:09 PM
How Is XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) Expected To Fare In The Coming Months?How Is XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) Expected To Fare In The Coming Months?
marketingsentinel.com - July 26 at 9:30 AM

Media Sentiment Over Time

Company Descriptions

Integrated BioPharma logo

Integrated BioPharma

OTCMKTS:INBP
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
Melinta Therapeutics logo

Melinta Therapeutics

NASDAQ:MLNT
Melinta Therapeutics, Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes various anti-infectives for the treatment of bacterial infectious diseases in North America. It offers Baxdela, a monotherapy treatment of adult patients with acute bacterial skin or skin structure infections (ABSSSIs); Vabomere, an IV antibiotic used in treatment of gram-negative infections; Orbactiv, an IV antibiotic of the lipoglycopeptide class for the treatment of adult patients with ABSSSIs; and Minocin, a IV antibiotic of the tetracycline class with activity against gram-positive and gram-negative pathogens. The company has license agreements with Yale University, Medical Research Council, Wakunaga Pharmaceutical Co., Ltd., and CyDex Pharmaceuticals, Inc. Melinta Therapeutics, Inc. was founded in 2000 and is headquartered in New Haven, Connecticut.
Reliv

Reliv' International

NASDAQ:RELV
Reliv' International, Inc. develops and markets nutritional supplements that address basic nutrition, specific wellness needs, weight management, and sports nutrition. The company's basic nutritional supplements are formulated to provide a balanced and complete level of supplementation for the consumer. Its principal products include Reliv Classic, Reliv Now, Innergize!, and FibRestore along with LunaRich X capsules. The company markets and sells its products through a direct selling system of independent distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, and the United Kingdom. Reliv' International, Inc. was founded in 1988 and is headquartered in Chesterfield, Missouri.

XTL Biopharmaceuticals

NASDAQ:XTLB
XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its pipeline includes hCDR1 and Erythropoietin. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.